Company Information
CIN
Status
Date of Incorporation
19 July 1994
State / ROC
Ahmedabad / ROC Ahmedabad
Last Balance Sheet
31 March 2021
Last Annual Meeting
28 September 2021
Paid Up Capital
545,677,650
Authorised Capital
1,205,100,000
Directors
Anup Pravin Shah
Director/Designated Partner
over 2 years ago
over 2 years ago
Shyamsunder Kashiram Sharma
Director/Designated Partner
over 2 years ago
over 2 years ago
Arjun Handa
Director/Designated Partner
about 11 years ago
about 11 years ago
Kirit Himatlal Kanjaria
Company Secretary
over 12 years ago
over 12 years ago
Chandrasingh Shivrambhai Purohit
Director/Designated Partner
about 16 years ago
about 16 years ago
Surrinder Lal Kapur
Director/Designated Partner
about 16 years ago
about 16 years ago
Aditya Sushilkumar Handa
Director/Designated Partner
over 16 years ago
over 16 years ago
Arvind Bansal
Director
about 17 years ago
about 17 years ago
Jatinkumar Rameshchandra Jalundhwala
Director
over 22 years ago
over 22 years ago
Past Directors
Chetankumar Satyendra Majmudar
Director
over 9 years ago
over 9 years ago
Milina Purnendu Bose
Additional Director
over 11 years ago
over 11 years ago
Tiruponitura Venkatraman Ananthanarayanan
Director
about 17 years ago
about 17 years ago
Hirenkumar Mahendrabhai Patel
Company Secretary
over 17 years ago
over 17 years ago
Amish Vyas Pravinchandra
Whole Time Director
about 19 years ago
about 19 years ago
Shankar Narayanan Madhava Menon
Nominee Director
over 19 years ago
over 19 years ago
Beena Sushilkumar Handa
Director
almost 26 years ago
almost 26 years ago
Patents
In the present invention is to provide an improved process for the preparation of bisphosphonic acid derivatives by, reacting carboxylic acid of structural formula (II),
with phosphonylating agents a mixture of phosphorous acid and halophosphorous compound, wherein halophosphorous compound is selected from the grou...
This invention relates to a novel and superior process of manufacturing Hydroxyethyl starch which is essentially free from pyrogen. It involves few unit operations, some of which are capable of performing in parallel, such as pretreatment of waxy starch, molecular size reduction by acid hydrolysis, attaching hydroxy...
The present invention relates to an improved process for the preparation of (Z)-(6R, 7R)-3-(acetoxymemyl)-7-[2-(2-amino-l,3-thiazol-4-yl)-2-methoxyiminoacetamido]-8-oxo-5-thia-]-
azabicyclo[4,2,0]oct-2-en-2-carboxylic acid is described, and to remove the by-product and to obtain require product with high purity and...
The invention is a sterile pharmaceutical composition for parenteral administration comprised of an oil-in-water emulsion, in which Propofol is dissolved in a water-immiscible lipophilic agents, and surface stabilizing amphiphilic agent, and tonicity modifying water-soluble hydroxy group and preservative preferably,...
The delivery by liposome technology gives us the advantage to deliver toxic drugs to the without causing damage to the normal cells. Also, many drugs with low aqueous solubility and/or combination of both water-soluble and lipid soluble drugs can be formulated in the liposomes, increasing the bioavailability of the ...
An improved process for producing pyrogen free Tetrastarch (130/0.4). This process involves hydrolyzing the waxy starch to achieve molecular weight distribution between 110,000 to 150,000 daltons and molar substitution between 0.35 to 0.45 is achieved by attachment of hydroxyethyl group. Organic solvent used till te...
The present invention relates to an improved process for the preparation of (Z)-(6R, 7R)-3-(acetoxymethyl)-7-[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetamido]-8-oxo-5-thia-l-azabicyclo[4,2,0]oct-2-en-2-carboxylic acid (Cefotaxime acid) is described, where S-(2-benzothiazolyl-2-(2-aminothiazol-4-yl)-2-methoxyimi...
The present invention relates to modified formulations of recombinant human glycoprotein having an in-vivo biological activity to increase the production of reticulocytes and red blood cells. A stearically stabilized unilamillar vesicles (SSUV) containing the said biopharmaceutical composition and process for prepar...
The invention relates to a new process for the synthesis of Disodium salt of (6R, 7R)-7-[[(2Z)-(2-A mino -4- thiazolyl) (methoxyimino) acetyl] amino ]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1, 2, 4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-carboxylic acid hemiheptahydrate is described, ...
The present invention is provides a cost effective process for the production of Hydroxy ethyl Starch (HES – 130 {Tetra Starch}). Wherein, 130 indicates the molecular weight of Hydroxy Ethyl Starch, which is 1,30,000 daltons. For the manufacturing Hydroxy ethyl starch various steps like hydrolysis of waxy maize star...
The present invention involves the manufacturing process of iron sucrose complexes. Iron sucrose is basically from the haemitinic therapeutic group. It is a complex between polynuclear iron (Fe+3) hydroxide in a sucrose molecule. The molecular weight of the iron sucrose complex is ranging from 34,000 to 60,000 Dalto...
An innovative method of using D.O.C. for generation of power and steam. After an extraction of oil from Caster seeds whatever is left is known as D.O.C. This D.O.C. has a potential to use in high-pressure fuel dized bed combustion boiler because of its good efficiency for burning and it's ash has good fusion point. ...
The delivery by liposome technology gives us the advantage to deliver toxic drugs to the target cells without causing damage to the normal cells. Also, many drugs with low aqueous solubility and/or combination of both water-soluble and lipid soluble drugs can be formulated in the liposomes, increasing the bioavailab...
An improved process of preparing purified waxy starch from such sources as maize, rice, potato and wheat is described so as to reduce the protein content. Waxy starch treated with alkali such as Sodium Hydroxide or Potassium Hydroxide at a specified pH range for a definite period of time. At the end of such period t...
The present invention relates to modified compositions of stericaliy stabilized
unilamellar vesicles for encapsulating recombinant proteins. More particularly,
recombinant human or animal or plant or microbial derived proteins.
glycoproteins, enzymes, peptides and their pharmaceutically acceptable
der...
The present invention relates to the process of purification of 2,6-diisopropyl phenol, the process of purification of 2,6-diisopropyl phenol by treating raw 2,6-diisopropyl phenol with solution of alkali metal soluble in alcohols at 0˚C to 5˚C, charging with solvents, washing with organic non-polar solvents, treati...
The present invention relates to an improved process for the preparation of (Z)-(6R, 7R)-3-(acetoxymethyl)-7-[2-(2-amino-lf3-thiazol-4-yl)-2-methoxyiminoacetamido]-8-oxo-5-tbia-l-azabicyclo[4,2J0]oct-2-en-2-carboxylic acid (Cefotaxime acid) is described, where S~(2-benzothiazolyl-2-(2-aminothiazol-4-yl)-2-methoxyimi...
The process for the preparation of (Z)-(6R, 7R)-3-(acetoxymethyl)-7-[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetamido]-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-en-2carboxylic acid (Cefotaxime acid) in presence of dichloromethane and suitable base to obtain require product with high yield.
In the present invention relates to process for the preparation of cephalosporin derivative- the process comprises condensing of 7-amino cephalosporanic acids with thiol derivatives to 3-thiodiazolyl derivatives of 7-ACA in the presence of condensing agent (boron trifluoride ethyl etherate) and weak acid, and acylat...
Registered Trademarks
[Class : 45] Legal Services, Security Services For The Protection Of Property And Individuals, Personal And Social Services Rendered By Others To Meet The Needs Of Individuals.
[Class : 43] Services For Providing Food And Drink, Temporary Accommodation.
[Class : 42] Scientific And Technological Services And Research And Design Relating Thereto, Industrial Analysis And Research Services, Design And Development Of Computer Hardware And Software.
View +80 more Brands for Claris Lifesciences Limited.
Charges
12 August 2016
Icici Bank Limited
23 Lak
24 May 2016
Icici Bank Limited
20 Lak
24 May 2016
Icici Bank Limited
37 Lak
24 May 2016
Icici Bank Limited
35 Lak
20 December 2017
Credit Suisse Ag
390 Crore
20 December 2017
Credit Suisse Ag
390 Crore
30 September 2016
Punjab National Bank
20 Crore
24 October 2013
Tata Capital Financial Services Limited
15 Crore
02 February 2015
Deutsche Bank Ag
74 Crore
23 July 2009
Canara Bank
335 Crore
17 November 2008
Canara Bank
335 Crore
03 November 2010
Central Of Bank India
47 Crore
24 February 2012
Canara Bank
72 Crore
25 March 2010
Allahabad Bank
30 Crore
06 April 2013
Vijaya Bank
50 Crore
29 April 2013
Canara Bank
50 Crore
03 December 2010
Central Bank Of India
40 Crore
25 September 2009
United Bank Of India
24 Crore
18 January 2012
Andhra Bank
24 Crore
15 December 2009
Indian Overseas Bank
14 Crore
15 December 2009
Indian Overseas Bank
7 Crore
25 October 2004
Citi Corp. Finance India Ltd.
7 Lak
14 February 2008
Canara Bank
339 Crore
29 May 2007
Canara Bank
222 Crore
04 February 2010
Allahabad Bank
25 Crore
14 November 2008
Punjab National Bank
30 Crore
06 November 2007
The Hongkong & Shanghai Banking Corporation Limited
112 Crore
28 March 2009
The Lakshmi Vilas Bank Ltd
56 Crore
24 December 2010
Allahabad Bank
25 Crore
05 November 2007
Canara Bank
16 Crore
13 July 2005
Sundram Finance Ltd.
7 Lak
29 June 2005
Sundram Finance Ltd.
14 Lak
11 July 2005
Sundram Finance Ltd.
6 Lak
31 May 2006
Centurion Bank Of Punjab Limited
13 Lak
31 July 2006
Centurion Bank Of Punjab Limited
10 Lak
31 May 2006
Centurion Bank Of Punjab Limited
13 Lak
31 July 2006
Centurion Bank Of Punjab Limited
10 Lak
31 May 2006
Centurion Bank Of Punjab Limited
13 Lak
31 May 2006
Centurion Bank Of Punjab Limited
13 Lak
02 September 2005
Centurion Bank Ltd.
7 Lak
16 July 2005
Centurion Bank Ltd.
9 Lak
31 July 2006
Centurion Bank Of Punjab Limited
6 Lak
04 July 2009
Central Bank Of India
40 Crore
31 July 2006
Centurion Bank Of Punjab Limited
10 Lak
29 December 2006
Centurion Bank Of Punjab Limited
11 Lak
29 December 2006
Centurion Bank Of Punjab Limited
11 Lak
29 December 2006
Centurion Bank Of Punjab Limited
11 Lak
29 December 2006
Centurion Bank Of Punjab Limited
11 Lak
17 November 2004
Centurion Bank Limited
22 Crore
17 November 2004
Centurion Bank Of Punjab Ltd.
153 Crore
01 May 2007
Centurion Bank Of Punjab
37 Crore
17 November 2004
Centuirion Bank Of Punjab
40 Crore
14 August 2007
Centurion Bank Of Punjab Ltd.
15 Crore
06 December 2007
Centurion Bank Of Punjab
15 Crore
17 November 2004
Centurion Bank Ltd.
3 Crore
05 March 2008
Indian Overseas Bank
69 Crore
31 March 2009
Andhra Bank
15 Crore
19 December 2006
Allahabad Bank
4 Crore
04 March 2008
Indian Overseas Bank
20 Crore
12 April 2007
Indian Overseas Bank
40 Crore
19 December 2006
Allahabad Bank
7 Crore
31 July 2006
Centurion Bank Of Punjab Limited
10 Lak
24 March 2008
Canara Bank
3 Crore
18 August 2004
Export Import Bank Of India
31 Crore
26 August 2003
Oriental Bank Of Commerce
4 Crore
23 August 2003
Oriental Bank Of Commerce
5 Crore
23 August 2003
Oriental Bank Of Commerce
0
